Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Vertex Pharmaceuticals Incorporated

TRADE

NASDAQ: VRTXHealthcare / Biotechnology / USA
180.12-1.01-0.56%Vol 1 044 5351Y Perf 12.70%
Jul 19th, 2018 16:00
BID171.52 ASK183.00
Open180.13 Previous Close181.13
Pre-Market- After-Trading180.12
 - -%  - -%
Target Price
190.42 
Analyst Rating
Strong Buy 1.34
Potencial %
5.72 
Finscreener Ranking
★★★+     53.46
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★+     44.35
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★★     70.82
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)45 900 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
93.03 
Earnings Date
25th Jul 2018

Today's Price Range

178.52180.93

 

52wk Range

136.50183.39

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
14.27%
3 Months
13.89%
6 Months
14.02%
1 Year
12.70%
3 Years
34.95%
5 Years
103.50%

Quotes

Name / TickerPriceChg.Chg.%
VRTX180.12-1.0100-0.56
AAPL191.881.48000.78
GOOG1 186.96-8.9200-0.75
MSFT104.40-0.7200-0.68
XOM82.01-0.2100-0.26
WFC56.33-0.2400-0.42
JNJ125.94-1.8600-1.46
FB208.09-1.2700-0.61
GE13.73-0.0200-0.15
JPM109.89-1.6400-1.47
...

TickerPriceChg.%52 Week High
SNA173.299.50185.47
DOV78.125.3088.11
DHR103.204.47106.08
SCG40.203.5368.35
SWN5.363.476.72
WMB28.693.3533.67
M38.963.3441.33
SIG60.663.3277.94
IBM149.243.27171.13
AZO716.173.19797.89
PDCO22.983.1443.20
ORLY299.233.00300.07
D72.002.9385.30
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.40
Current Ratio 3.70
Long Term Debt to Total Capital 0.19
Total Debt to Equity 0.25
Interest Coverage -0.10
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin87.60
EBIT Margin-0.10
EBITDA Margin2.50
Pre-tax Profit Margin-53.20
Profit Margin2.11
ValuationValueIndustryS&P 500US Markets
PE Ratio 207.50
PB Ratio 19.16
PS Ratios 25.43
Price to Cash Flow 55.50
Price to Free Cash Flow 117.80
Cash Flow Per Share 3.25
Price to Tangible Book19.81
Book Value per Share9.42
Enterprise Value (in ths.)44 115 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-26.30
ROE last 12 Months 11.59
Return on Assets (5Y Avg) -9.21
ROA last 12 Months 6.55
Return on Capital (5Y Avg) -15.07
ROC last 12 Months 10.46
Return on invested Capital Q 7.75
Return on invested Capital Y12.85
Assets Turnover0.20
Receivables Turnover3.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 808 600
Revenue per Share 7.10
Revenue Growth 3 Years 46.76
Revenue Growth 5 Years 20.35
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 20180.280.5492.86
Q04 20170.290.3210.34
Q03 20170.040.24500.00
Q02 20170.060.1066.67
Q01 20170.040.13225.00
Q04 2016-0.010.131 400.00
Q03 2016-0.06-0.09-50.00
Q02 2016-0.02-0.0150.00
Earnings Per EndEstimateRevision %Trend
6/2018 QR0.4220.00Positive
9/2018 QR0.494.26Positive
12/2018 FY1.9516.77Positive
12/2019 FY3.07--
Next Report Date25th Jul 2018
Estimated EPS Next Report0.40
Estimates Count8
EPS Growth Next 5 Years %42.00
Volume Overview
Volume1 044 535
Shares Outstanding (in ths.)254 830
Trades Count5 064
Dollar Volume139 342 600
Avg. Volume1 693 454
Avg. Weekly Volume1 287 444
Avg. Monthly Volume1 735 846
Avg. Quarterly Volume1 642 191

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

58%42%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
14 (73.68 %)
15 (71.43 %)
15 (71.43 %)
Moderate Buy
3 (15.79 %)
4 (19.05 %)
4 (19.05 %)
Hold
2 (10.53 %)
2 (9.52 %)
2 (9.52 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.34
Strong Buy
1.36
Strong Buy
1.36

There are no comments yet.

News

x